SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001104659-23-122096
Filing Date
2023-11-29
Accepted
2023-11-29 17:16:21
Documents
2
Period of Report
2023-11-17

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2331695-1_3seq1.html 3  
1 OWNERSHIP DOCUMENT tm2331695-1_3seq1.xml 3 1590
2 EXHIBIT 24 tm2331695d1_ex24.htm EX-24 5547
  Complete submission text file 0001104659-23-122096.txt   8657
Mailing Address 1111 MAIN STREET, SUITE 660 VANCOUVER WA 98660
Business Address 1111 MAIN STREET, SUITE 660 VANCOUVER WA 98660 360-980-8524
CytoDyn Inc. (Issuer) CIK: 0001175680 (see all company filings)

IRS No.: 753056237 | State of Incorp.: DE | Fiscal Year End: 0531
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1111 MAIN STREET SUITE 660 VANCOUVER WA 98660
Business Address
Lalezari Jacob P (Reporting) CIK: 0002001963 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-49908 | Film No.: 231453317